The National Institutes of Health and 11 leading biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaboration totaling $215 million as part of the Cancer Moonshot. PACT will initially focus on efforts to identify, develop and validate robust biomarkers — standardized biological markers …
Tag Archives: NIH
October, 2017
September, 2017
-
21 September
Sanofi and NIH Researchers Develop Three-in-One Antibodies to Treat HIV
CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire/ — In a landmark study published in the journal Science today, researchers produced genetically engineered antibodies with the highest activity and breadth of coverage yet seen against human immunodeficiency virus (HIV-1). Natural antibodies recognize a single target on a foreign protein. In this study, …
August, 2017
-
7 August
NCI Study Identifies Essential Genes for Cancer Immunotherapy
A new study identifies genes that are necessary in cancer cells for immunotherapy to work, addressing the problem of why some tumors don’t respond to immunotherapy or respond initially but then stop as tumor cells develop resistance to immunotherapy. The study, from the National Cancer Institute (NCI), was led by Nicholas …
May, 2017
-
26 May
President’s Budget Threatens to Stall Nation’s Progress Against Cancer
ASCO strongly opposes the Administration’s proposed cuts to federal agencies that support biomedical research and Medicaid for Fiscal Year 2018, including a 21 percent proposed funding cut for the National Institutes of Health (NIH), a 20 percent proposed funding cut for the National Cancer Institute (NCI), and reducing Medicaid funding …
April, 2017
-
17 April
Rates of New Diagnosed Cases of Type 1 and 2 Diabetes on the Rise Among Children, Teens
Rates of new diagnosed cases of type 1 and type 2 diabetes are increasing among youth in the United States, according to a report, Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012, published today in the New England Journal of Medicine. In the United States, 29.1 …
March, 2017
-
24 March
Facial Recognition Software Helps Diagnose Rare Genetic Disease
Researchers with the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, and their collaborators, have successfully used facial recognition software to diagnose a rare, genetic disease in Africans, Asians and Latin Americans. The disease, 22q11.2 deletion syndrome, also known as DiGeorge syndrome and velocardiofacial syndrome, …
December, 2016
-
12 December
Kite Pharma Announces Publication of T-Cell Therapy Targeting Mutant KRAS in Cancer by the NCI in NEJM
SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc. (Nasdaq:KITE) announced today that characterizations of T cell receptor candidates which it has licensed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the December 8, 2016 New England Journal of Medicine (NEJM). The …
September, 2016
-
19 September
VP Biden Announces New Steps to Improve Clinical Trials Essential to Advancing the Cancer Moonshot
“These steps will improve the safety, accessibility and impact of our clinical research system. They will help patients today and help researchers all over the world in their quests to find new cures. And they come at a true inflection point in our fight against cancer. “Clinical trials are essential …
-
14 September
Aphios to Develop Cure for HIV/AIDS Using Combination Drugs in Targeted ‘Nanosomes’ Nanoparticles
WOBURN, Mass.–(BUSINESS WIRE)–Aphios Corporation today announced that it plans to continue its research to develop a cure for HIV/AIDS using combination drugs in targeted ‘nanosomes’ nanoparticles with recent funding from the National Institute of Allergy and Infectious Diseases (NIAID), NIH. Currently, about 35 million people have died from AIDS and …
August, 2016
-
31 August
Study Finds Potential New Biomarker for Cancer Patient Prognosis
To treat or not to treat? That is the question researchers at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing. Berkeley Lab researchers identified …